F. Tas Et Al. , "Triplet chemotherapy combination with cisplatin, gemcitabine and docetaxel in patients with chemotherapy-naive advanced non-small cell lung cancer," ONCOLOGY LETTERS , vol.5, no.5, pp.1699-1703, 2013
Tas, F. Et Al. 2013. Triplet chemotherapy combination with cisplatin, gemcitabine and docetaxel in patients with chemotherapy-naive advanced non-small cell lung cancer. ONCOLOGY LETTERS , vol.5, no.5 , 1699-1703.
Tas, F., Sen, F., Guney, N., Keskin, S., & Camlica, H., (2013). Triplet chemotherapy combination with cisplatin, gemcitabine and docetaxel in patients with chemotherapy-naive advanced non-small cell lung cancer. ONCOLOGY LETTERS , vol.5, no.5, 1699-1703.
Tas, Faruk Et Al. "Triplet chemotherapy combination with cisplatin, gemcitabine and docetaxel in patients with chemotherapy-naive advanced non-small cell lung cancer," ONCOLOGY LETTERS , vol.5, no.5, 1699-1703, 2013
Tas, Faruk Et Al. "Triplet chemotherapy combination with cisplatin, gemcitabine and docetaxel in patients with chemotherapy-naive advanced non-small cell lung cancer." ONCOLOGY LETTERS , vol.5, no.5, pp.1699-1703, 2013
Tas, F. Et Al. (2013) . "Triplet chemotherapy combination with cisplatin, gemcitabine and docetaxel in patients with chemotherapy-naive advanced non-small cell lung cancer." ONCOLOGY LETTERS , vol.5, no.5, pp.1699-1703.
@article{article, author={Faruk TAŞ Et Al. }, title={Triplet chemotherapy combination with cisplatin, gemcitabine and docetaxel in patients with chemotherapy-naive advanced non-small cell lung cancer}, journal={ONCOLOGY LETTERS}, year=2013, pages={1699-1703} }